Each project or product is defined by its use and by its regulations. This is why since the beginning of our project, we have wanted to integrate the opinion of those who shall use it, farmers, and those who will authorize it, lawyers.

To integrate the farmer’s opinion, we contacted them and did a survey, first via the web, and then in person, during events around agriculture. This approach helped us to figure out their needs and their thoughts, about Xylella fastidiosa and the communication around it. ...

We got advice from different experts : Mireille Ansaldi, the research director of the phage cycle and bacteria metabolism in LCB CNRS ; Marie-Agnès Jacques, INRA’s researcher specialised in Xylella fastidiosa, and Jacques Van Helden, professor in Aix-Marseille Université in bioinformatics, genome analysis, and more specifically analyses of regulatory sequences.

These three experts helped us a great deal. Ms. Ansaldi first guided us toward the phage M13 because we wanted to use a bacteriophage to get rid of Xyllela fastidiosa. In the end, we didn’t, but we did use phages as a specific capsule.

Then, when we began dry lab work, M. Van Helden help us with our human practices questioning about specificity and controllability of our project.

Finally, in order to get advice on the relevance of our project, we contacted Ms. Jacques, a Xyllela fastidiosa specialist from the INRA (Institut National de la Recherche Agronomique). She beware us that we would be defined by the legislation as a GMO product. We then began a complete study of french’s and European's law to see if we will be able to sell our product in France and in Europe.